Efecto de la aspirina en la prevención de la preeclampsia. Revisión bibliográfica

Pre-eclampsia is a hypertensive disorder arising during pregnancy characterised by elevated blood pressure and complications such as proteinuria, organ dysfunction and uteroplacental dysfunction. Aspirin, a non-steroidal anti-inflammatory drug, is used in the prevention of pre-eclampsia. This review aims to establish the effect of aspirin as a preventive measure for pre-eclampsia in pregnant women through a systemic review. The study is descriptive-explanatory and relies on articles from scientific databases, including PubMed, Scielo, Cochrane and Google Scholar, using key terms such as ‘aspirin’, ‘pre-eclampsia’ and ‘prevention’. The findings suggest that aspirin administration, particularly at low doses (81 mg/day), significantly reduces the incidence of pre-eclampsia and associated complications, such as preterm birth and perinatal mortality. However, questions remain about the optimal dose and timing of administration. Aspirin has a favourable safety profile and is an effective preventive strategy, although further studies are needed to precise the conditions for its us.